EFFICACY OF ADJUVANT 9-WEEKS TRASTUZUMAB IN NODE-NEGATIVE T1A/B HER2-POSITIVE BREAST CANCER

Şendur, Mehmet Ali NahitAksoy, SercanUncu, DoğanDemir, H.Yuksel, S.Ekinci, Ahmet SiyarKaplan, A.2020-03-262020-03-2620140923-75341569-8041https://dx.doi.org/10.1093/annonc/mdu327.44https://hdl.handle.net/20.500.12395/3080739th ESMO Congress (ESMO) -- SEP 26-30, 2014 -- Madrid, SPAIN[Abstract not Available]en10.1093/annonc/mdu327.44info:eu-repo/semantics/openAccessEFFICACY OF ADJUVANT 9-WEEKS TRASTUZUMAB IN NODE-NEGATIVE T1A/B HER2-POSITIVE BREAST CANCERConference Object25WOS:000346901000167Q1